Breast Cancer
PTHrP expression is predictive of longer survival in breast cancer
Published in Clinical Oncology Week, June 30th, 2003
"Parathyroid hormone-related peptide (PTHrP) participates in the development of humoral hypercalcemia of malignancy. The peptide is thought to affect growth and differentiation of normal and neoplastic cells. The present study aimed at evaluation of the relationship between survival time and development of distant metastases in patients with ductal mammary carcinoma on the one hand and PTHrP expression on the other," scientists writing in the journal Virchows Archiv report.
"Immunocytochemical reactions using mouse monoclonal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Autoimmune Disease
Patients testing positive for anti-Hu antibodies may have underlying cancer - Non-Small Cell Lung Cancer
Combination of "smart drugs" may work for bronchioalveolar carcinoma - Breast Cancer
Epirubicin clinical trial shows treatment improves survival rate - Pancreatic Cancer
Reversing chronic pancreatitis may reduce conversion to pancreatic cancer - Pancreatic Neoplasms
Helical CT and advanced postprocessing techniques are diagnostically effective - Tumoral Calcinosis
Angiography shows margins, which influences management and surgical approach - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
